Serum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndrome

dc.contributor.authorEren, Erdal
dc.contributor.buuauthorAbuhandan, Mahmut
dc.contributor.buuauthorSolmaz, Abdullah
dc.contributor.buuauthorTaşkın, Abdullah
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı.tr_TR
dc.contributor.researcheridABF-5740-2020tr_TR
dc.contributor.scopusid6603208583tr_TR
dc.contributor.scopusid55941048500tr_TR
dc.contributor.scopusid35204100300tr_TR
dc.date.accessioned2024-03-01T05:46:53Z
dc.date.available2024-03-01T05:46:53Z
dc.date.issued2014-07-07
dc.description.abstractObjective: This study aimed to measure paraoxonase/arylesterase activities and to evaluate the total oxidant and antioxidant capacities in obese children and in children with metabolic syndrome (MetS). Methods: A total of 151 children of comparable ages (13.23+/-1.96 years, 13.45+/-1.85 years and 13.95+/-1.31 years) were enrolled in the study. Forty of these were children with MetS, 55 were obese and 56 were healthy controls. Diagnosis of the MetS was made according to International Diabetes Federation criteria. Paraoxonase/arylesterase activities were evaluated by using paraoxon and phenylacetate substrates. Total oxidant status (TOS) and total antioxidant status (TAS) were measured and oxidative stress index (OSI) was estimated by calculation. Results: High levels of paraoxonase were detected in the obese group, whereas high levels of arylesterase were detected in both MetS and obese groups. Higher values for TOS, TAS and OSI were found in the MetS group (p<0.05). Conclusion: Higher values of mean TOS and OSI in the MetS group than those in the control groups indicate that these parameters may be indicators of future risks such as atherosclerosis in patients with MetS.en_US
dc.identifier.citationEren, E. vd. (2014). "Serum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndrome". JCRPE Journal of Clinical Research in Pediatric Endocrinology, 6(3), 163-168.en_US
dc.identifier.doihttps://doi.org/10.4274/jcrpe.1454en_US
dc.identifier.eissn1308-5735
dc.identifier.endpage168tr_TR
dc.identifier.issn1308-5727
dc.identifier.issue3tr_TR
dc.identifier.pubmed25241610tr_TR
dc.identifier.scopus2-s2.0-84908218387tr_TR
dc.identifier.startpage163tr_TR
dc.identifier.urihttps://cms.galenos.com.tr/Uploads/Article_1191/163-168.pdfen_US
dc.identifier.urihttps://hdl.handle.net/11452/40116en_US
dc.identifier.volume6tr_TR
dc.identifier.wos000347784500005tr_TR
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherGalenos Yayıncılıken_US
dc.relation.collaborationYurt içitr_TR
dc.relation.journalJCRPE Journal of Clinical Research in Pediatric Endocrinologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMetabolic syndromeen_US
dc.subjectPediatricsen_US
dc.subjectObesityen_US
dc.subjectEndocrinology & metabolismen_US
dc.subjectOxidative stressen_US
dc.subjectPon1 activityen_US
dc.subjectParaoxonaseen_US
dc.subjectRisk-factorsen_US
dc.subjectFatty liver-diseaseen_US
dc.subjectAdipokine levelsen_US
dc.subjectC-reactive proteinen_US
dc.subjectAutomated-methoden_US
dc.subjectInsulin-resistanceen_US
dc.subjectChildhood obesityen_US
dc.subjectObese childrenen_US
dc.subjectParaoxonase activityen_US
dc.subject.emtreeAdolescenten_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBody heighten_US
dc.subject.emtreeBody massen_US
dc.subject.emtreeChilden_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeEnzyme activityen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeInsulin resistanceen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMetabolic syndrome xen_US
dc.subject.emtreeObesityen_US
dc.subject.emtreeOxidative stressen_US
dc.subject.emtreeSchool childen_US
dc.subject.emtreeWaist circumferenceen_US
dc.subject.emtreeBlooden_US
dc.subject.emtreeCase control studyen_US
dc.subject.emtreeEnzymologyen_US
dc.subject.emtreeMetabolic syndrome xen_US
dc.subject.emtreePediatric obesityen_US
dc.subject.emtreePredictive valueen_US
dc.subject.emtreeRisk factoren_US
dc.subject.emtreeUpregulationen_US
dc.subject.emtreeAryldialkylphosphataseen_US
dc.subject.emtreeArylesteraseen_US
dc.subject.emtreeOxidizing agenten_US
dc.subject.emtreeAntioxidanten_US
dc.subject.emtreeAryldialkylphosphataseen_US
dc.subject.emtreeBiological markeren_US
dc.subject.emtreeC reactive proteinen_US
dc.subject.emtreePon1 protein, humanen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAntioxidantsen_US
dc.subject.meshAryldialkylphosphataseen_US
dc.subject.meshBiomarkersen_US
dc.subject.meshC-reactive proteinen_US
dc.subject.meshCase-control studiesen_US
dc.subject.meshChilden_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMetabolic syndrome xen_US
dc.subject.meshOxidative stressen_US
dc.subject.meshPediatric obesityen_US
dc.subject.meshPredictive value of testsen_US
dc.subject.meshRisk factorsen_US
dc.subject.meshUp-regulationen_US
dc.subject.scopusAryldialkylphosphatase; Arylesterase; Oxidative Stressen_US
dc.subject.wosEndocrinology & metabolismen_US
dc.subject.wosPediatricsen_US
dc.titleSerum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndromeen_US
dc.typeArticleen_US
dc.wos.quartileQ4 (Endocrinology & metabolism)en_US
dc.wos.quartileQ2 (Pediatrics)en_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Abuhandan_vd_2014
Size:
112.58 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections